These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34836952)

  • 21. Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk population.
    Meiss AE; Thomas M; Modesitt SC; Ring KL; Atkins KA; Mills AM
    Hum Pathol; 2018 Dec; 82():20-31. PubMed ID: 29958926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.
    Przybytkowski E; Davis T; Hosny A; Eismann J; Matulonis UA; Wulf GM; Nabavi S
    BMC Cancer; 2020 Mar; 20(1):197. PubMed ID: 32164626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults.
    Watanabe T; Honda T; Totsuka H; Yoshida M; Tanioka M; Shiraishi K; Shimada Y; Arai E; Ushiama M; Tamura K; Yoshida T; Kanai Y; Kohno T
    Breast Cancer Res Treat; 2020 Jul; 182(2):491-502. PubMed ID: 32488393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ancestral characterization of 1018 cancer cell lines highlights disparities and reveals gene expression and mutational differences.
    Kessler MD; Bateman NW; Conrads TP; Maxwell GL; Dunning Hotopp JC; O'Connor TD
    Cancer; 2019 Jun; 125(12):2076-2088. PubMed ID: 30865299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
    Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
    Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
    Larsen V; Barlow WE; Yang JJ; Zhu Q; Liu S; Kwan ML; Ergas IJ; Roh JM; Hutchins LF; Kadlubar SA; Albain KS; Rae JM; Yeh IT; Ravdin PM; Martino S; Lyss AP; Osborne CK; Hortobagyi GN; Kushi LH; Hayes DF; Ambrosone CB; Yao S
    Clin Breast Cancer; 2019 Aug; 19(4):225-235.e2. PubMed ID: 30928413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of GATA3 exon 6 germline mutations in breast cancer progression in Egyptian female patients.
    Ibrahim IH; Abdel-Aziz HG; Hassan FE; El-Sameea HS
    Exp Biol Med (Maywood); 2021 Jan; 246(1):40-47. PubMed ID: 32938228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data.
    Haricharan S; Bainbridge MN; Scheet P; Brown PH
    Breast Cancer Res Treat; 2014 Jul; 146(1):211-20. PubMed ID: 24839032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers.
    Zheng Y; Ogundiran TO; Falusi AG; Nathanson KL; John EM; Hennis AJ; Ambs S; Domchek SM; Rebbeck TR; Simon MS; Nemesure B; Wu SY; Leske MC; Odetunde A; Niu Q; Zhang J; Afolabi C; Gamazon ER; Cox NJ; Olopade CO; Olopade OI; Huo D
    Carcinogenesis; 2013 Jul; 34(7):1520-8. PubMed ID: 23475944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women.
    Loo LW; Wang Y; Flynn EM; Lund MJ; Bowles EJ; Buist DS; Liff JM; Flagg EW; Coates RJ; Eley JW; Hsu L; Porter PL
    Breast Cancer Res Treat; 2011 May; 127(1):297-308. PubMed ID: 21264507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.
    Hurst Z; Liyanarachchi S; He H; Brock P; Sipos J; Nabhan F; Kebebew E; Green P; Cote GJ; Sherman S; Walker CJ; Chang YS; Xue S; Hollingsworth B; Li W; Genutis L; Menq E; de la Chapelle A; Jhiang SM
    Thyroid; 2019 Apr; 29(4):530-539. PubMed ID: 30654714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
    Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
    Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer disparities: high-risk breast cancer and African ancestry.
    Newman LA
    Surg Oncol Clin N Am; 2014 Jul; 23(3):579-92. PubMed ID: 24882352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
    Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
    Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.
    Zhang B; Fackenthal JD; Niu Q; Huo D; Sveen WE; DeMarco T; Adebamowo CA; Ogundiran T; Olopade OI
    Fam Cancer; 2009; 8(1):15-22. PubMed ID: 18679828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures.
    Kan Z; Ding Y; Kim J; Jung HH; Chung W; Lal S; Cho S; Fernandez-Banet J; Lee SK; Kim SW; Lee JE; Choi YL; Deng S; Kim JY; Ahn JS; Sha Y; Mu XJ; Nam JY; Im YH; Lee S; Park WY; Nam SJ; Park YH
    Nat Commun; 2018 Apr; 9(1):1725. PubMed ID: 29713003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single Cell Genomics for Tumor Heterogeneity.
    Lee HO; Park WY
    Adv Exp Med Biol; 2021; 1187():205-214. PubMed ID: 33983580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome instability in blood cells of a BRCA1+ breast cancer family.
    Xiao F; Kim YC; Snyder C; Wen H; Chen PX; Luo J; Becirovic D; Downs B; Cowan KH; Lynch H; Wang SM
    BMC Cancer; 2014 May; 14():342. PubMed ID: 24884718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.